Results 51 to 60 of about 114,614 (335)

How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia

open access: yesFrontiers in Pharmacology, 2019
Objectives: The aim of this study was to review the impact of new reimbursement requirements for medicines in the Slovak Republic based on legislation that came into force in January 2018.Methods: The new legislation was reviewed.
Tomas Tesar   +4 more
doaj   +1 more source

Medicare 1971: Changing Attitudes and Changing Legislation [PDF]

open access: yes, 1970
Bone conduction (BC) is the way sound energy is transmitted by the skull bones to the cochlea causing a sound perception. Even if the BC sound transmission involves several pathways including sound pressure induced in the ear canal, inertial forces ...
Wolkstein, Irwin
core   +3 more sources

Accuracy of Diagnostic Codes and Algorithms Used to Identify Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in Administrative Claims and Electronic Health Records: Systematic Review and Meta‐Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records. Methods We searched Medline, Embase, and Cochrane Central Register for Controlled Trials databases and included studies that validated case definitions against a ...
Constanza Saka‐Herrán   +10 more
wiley   +1 more source

Value-Based Payment System and Consideration of Radiology

open access: yesJournal of the Korean Society of Radiology
The value-based payment (VBP) system aims to improve the quality of healthcare while enhancing cost-efficiency, delivering better patient outcomes without increasing overall healthcare costs.
Choong Wook Lee
doaj   +1 more source

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria

open access: yesBalkan Medical Journal, 2016
Background: During times of fiscal austerity, means of reimbursement decision-making are of particular interest for public health theory and practice. Introduction of advanced health technologies, growing health expenditures and increased public scrutiny
Georgi Iskrov, Rumen Stefanov
doaj   +1 more source

Antimicrobial Efficacy of a Taurolidine‐Based Antimicrobial Compound on Contaminated Surfaces Simulated in a Standardized 4‐Field Test

open access: yesAdvanced Healthcare Materials, EarlyView.
As implantable medical devices become indispensable to modern medicine, a silent threat grows alongside them: device‐associated infections. Despite decades of antibiotic innovation, infection rates keep climbing, costing lives and billions in healthcare expenses.
Benito Baldauf   +5 more
wiley   +1 more source

Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management

open access: yesHematology, Transfusion and Cell Therapy, 2021
Introduction: Chronic Myeloid Leukemia (CML) is a myeloproliferative disease that affects mainly adults between 50 and 55 years. In Brazil, information from the Sistema Único de Saúde (SUS) Outpatient Information System indicates that 12,531 patients had
Carla Maria Boquimpani   +5 more
doaj   +1 more source

Materials and System Design for Self‐Decision Bioelectronic Systems

open access: yesAdvanced Materials, EarlyView.
This review highlights how self‐decision bioelectronic systems integrate sensing, computation, and therapy into autonomous, closed‐loop platforms that continuously monitor and treat diseases, marking a major step toward intelligent, self‐regulating healthcare technologies.
Qiankun Zeng   +9 more
wiley   +1 more source

Comparison of Provisions from Colorado's Blue Ribbon Commission for Health Care Reform and Federal Health Care Reform [PDF]

open access: yes, 2010
A new issue brief commissioned by The Colorado Trust, and authored by the two lead staff members of the Colorado's Blue Ribbon Commission on Healthcare Reform (the 208 Commission), Tracy L.
Sarah Schulte, Tracy L. Johnson
core  

Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome

open access: yesAdvanced Science, EarlyView.
Pharmacological SUMOylation inhibition (SUMOi) counteracts tumor immune evasion by unmasking an immunogenic HLA‐I peptide and neoepitope repertoire. By restoring HLA‐I ligand availability through increased antigen processing and presentation, enhanced proteasomal cleavage, and modulated TAP1 peptide affinity, SUMOi boosts tumor immunogenicity ...
Uta M. Demel   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy